286 related articles for article (PubMed ID: 16027250)
1. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study.
Johnsen SH; Mathiesen EB; Fosse E; Joakimsen O; Stensland-Bugge E; Njølstad I; Arnesen E
Circulation; 2005 Jul; 112(4):498-504. PubMed ID: 16027250
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study.
Qi Y; Fan J; Liu J; Wang W; Wang M; Sun J; Liu J; Xie W; Zhao F; Li Y; Zhao D
J Am Coll Cardiol; 2015 Feb; 65(4):355-363. PubMed ID: 25634834
[TBL] [Abstract][Full Text] [Related]
3. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study.
Johnsen SH; Mathiesen EB; Joakimsen O; Stensland E; Wilsgaard T; Løchen ML; Njølstad I; Arnesen E
Stroke; 2007 Nov; 38(11):2873-80. PubMed ID: 17901390
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
Watanabe K; Sugiyama S; Kugiyama K; Honda O; Fukushima H; Koga H; Horibata Y; Hirai T; Sakamoto T; Yoshimura M; Yamashita Y; Ogawa H
J Am Coll Cardiol; 2005 Dec; 46(11):2022-30. PubMed ID: 16325036
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.
Herder M; Johnsen SH; Arntzen KA; Mathiesen EB
Stroke; 2012 Jul; 43(7):1818-23. PubMed ID: 22550052
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of lipid-lowering drugs slows progression of carotid atherosclerosis: the Tromso study 1994 to 2008.
Herder M; Arntzen KA; Johnsen SH; Eggen AE; Mathiesen EB
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):858-62. PubMed ID: 23393396
[TBL] [Abstract][Full Text] [Related]
7. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: the tromsø study.
Mathiesen EB; Bønaa KH; Joakimsen O
Stroke; 2001 Sep; 32(9):1960-5. PubMed ID: 11546881
[TBL] [Abstract][Full Text] [Related]
8. The association between inflammatory markers and carotid atherosclerosis is sex dependent: the Tromsø Study.
Halvorsen DS; Johnsen SH; Mathiesen EB; Njølstad I
Cerebrovasc Dis; 2009; 27(4):392-7. PubMed ID: 19276622
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study.
Kronborg J; Johnsen SH; Njølstad I; Toft I; Eriksen BO; Jenssen T
Diabetologia; 2007 Aug; 50(8):1607-14. PubMed ID: 17558484
[TBL] [Abstract][Full Text] [Related]
11. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study.
Johnsen SH; Fosse E; Joakimsen O; Mathiesen EB; Stensland-Bugge E; Njølstad I; Arnesen E
Stroke; 2005 Apr; 36(4):715-9. PubMed ID: 15746459
[TBL] [Abstract][Full Text] [Related]
12. Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study.
Lappegård J; Ellingsen TS; Vik A; Skjelbakken T; Brox J; Mathiesen EB; Johnsen SH; Brækkan SK; Hansen JB
Thromb Haemost; 2015 Mar; 113(3):649-54. PubMed ID: 25631329
[TBL] [Abstract][Full Text] [Related]
13. Vascular risk factors for atherosclerotic plaque progression in carotid artery.
Delcker A; Diener HC; Wilhelm H
Int Angiol; 1995 Dec; 14(4):339-45. PubMed ID: 8708424
[TBL] [Abstract][Full Text] [Related]
14. Echogenicity of medium-to-large carotid plaques predicts future vascular events.
Tadokoro Y; Sakaguchi M; Yamagami H; Okazaki S; Furukado S; Matsumoto M; Miwa K; Yagita Y; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2014; 38(5):354-61. PubMed ID: 25427642
[TBL] [Abstract][Full Text] [Related]
15. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women.
Masson W; Siniawski D; Lobo M; Molinero G; Huerín M
Endocrinol Nutr; 2016; 63(7):327-32. PubMed ID: 27236636
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of Lipid Profile and Risk of Carotid Atherosclerosis Progression: A Longitudinal Cohort Study.
Yu H; Li Y; Tao L; Yang L; Liu D; Wang Y; Hao X; He H; Che Y; Wang P; Zhao W; Gao W
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956420
[TBL] [Abstract][Full Text] [Related]
17. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis.
Tamada M; Makita S; Abiko A; Naganuma Y; Nagai M; Nakamura M
Metabolism; 2010 May; 59(5):653-7. PubMed ID: 19913853
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study.
Eltoft A; Arntzen KA; Hansen JB; Wilsgaard T; Mathiesen EB; Johnsen SH
Atherosclerosis; 2017 Aug; 263():293-300. PubMed ID: 28728065
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly.
Lind PM; Lind L
Atherosclerosis; 2011 Sep; 218(1):207-13. PubMed ID: 21621210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
